R&D | May 28, 2026
Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Under the new initiative, each company takes on a defined role across the recycling chain
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
The company highlighted continued demand strength and pricing resilience despite global disruptions
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
The move signals a major expansion milestone for the Swiss laboratory automation company
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
